Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 65

    Dr Reddys Srikakulam plant gets 4 USFDA observations

    Dr Reddys Srikakulam plant gets 4 USFDA observations

    Farhat Nasim29 Oct 2019 10:00 AM IST
    The audit of Dr Reddy's API Srikakulam Plant (SEZ) by the United States Food and Drug Administration (USFDA) was completed on Friday, the...
    New tuberculosis treatment to be available in India at Rs 73572

    New tuberculosis treatment to be available in India at Rs 73572

    Farhat Nasim29 Oct 2019 9:32 AM IST
    New Delhi: A newly-approved three-drug treatment for tuberculosis will be available in 150 countries including India and South Africa, priced at...
    Macleods Pharma recalls diabetes drug Pioglitazone Hydrochloride tablets in US

    Macleods Pharma recalls diabetes drug Pioglitazone Hydrochloride tablets in US

    Farhat Nasim29 Oct 2019 9:30 AM IST
    Pioglitazone Hydrochloride tablets being recalled are in the strength of 15 mg and have been manufactured by Macleods Pharmaceuticals in its Baddi...
    Synthetic stimulant drug Mephedrone worth Rs 3.5 crore seized from Rajdhani Express, 2 held

    Synthetic stimulant drug Mephedrone worth Rs 3.5 crore seized from Rajdhani Express, 2 held

    Farhat Nasim29 Oct 2019 9:20 AM IST
    The Directorate of Revenue Intelligence official said a team, acting on a tip-off, boarded the Mumbai-bound Rajdhani Express on Saturday morning and...
    Alkem Labs Bioeguivalcnce Center at Taloja clears USFDA inspection

    Alkem Labs Bioeguivalcnce Center at Taloja clears USFDA inspection

    Medical Dialogues Bureau28 Oct 2019 10:00 AM IST
    "This is to inform that the US FDA had conducted an inspection at Alkem Laboratories Ltd's Bioequivalence Center located at Taloja, Maharashtra from...
    Piramal Enterprises plans to raise upto Rs 1000 crore via NCDs

    Piramal Enterprises plans to raise upto Rs 1000 crore via NCDs

    Medical Dialogues Bureau28 Oct 2019 9:45 AM IST
    The administrative committee of the board approved the issue of secured NCDs on private placement basis up to Rs 500 crore with an option to retain...
    Alembic Pharma international formulations grew 10pc to Rs 646 crore in Q2

    Alembic Pharma international formulations grew 10pc to Rs 646 crore in Q2

    Medical Dialogues Bureau28 Oct 2019 9:30 AM IST
    Alembic said its international formulations grew 10 per cent to Rs 646 crore in the quarter under review and 17 per cent to Rs 1,099 crore in the...
    Foamix Pharma wins USFDA nod for Amzeeq, topical minocycline treatment for acne

    Foamix Pharma wins USFDA nod for Amzeeq, topical minocycline treatment for acne

    Medical Dialogues Bureau28 Oct 2019 9:15 AM IST
    “The USFDA approval of AMZEEQ ((minocycline) topical foam, is a milestone moment in dermatology and the most significant advancement with minocycline...
    Alexion Pharma to acquire clinical-stage biopharmaceutical firm Achillion

    Alexion Pharma to acquire clinical-stage biopharmaceutical firm Achillion

    Medical Dialogues Bureau28 Oct 2019 9:00 AM IST
    New Delhi: Alexion Pharmaceuticals, Inc. and Achillion Pharmaceuticals, Inc. recently announced that they have entered into a definitive agreement...
    Jubilant Life gets ANDA final nod for Clomipramine Hydrochloride Capsules to treat OCD

    Jubilant Life gets ANDA final nod for Clomipramine Hydrochloride Capsules to treat OCD

    Medical Dialogues Bureau27 Oct 2019 10:00 AM IST
    New Delhi: Jubilant Life Sciences Ltd recently announced that Jubilant Pharma Limited, a material wholly-owned subsidiary of the Company, through one...
    Novartis boosts 2019 forecasts as Cosentyx, Zolgensma shine

    Novartis boosts 2019 forecasts as Cosentyx, Zolgensma shine

    Medical Dialogues Bureau27 Oct 2019 9:45 AM IST
    Zolgensma, the $2.1 million-per-patient treatment for spinal muscular atrophy, posted $160 million in sales. Novartis now anticipated approval in...
    Strides Pharma reports revenue of Rs 718 crore for Q2

    Strides Pharma reports revenue of Rs 718 crore for Q2

    Medical Dialogues Bureau27 Oct 2019 9:32 AM IST
    EBITDA margins stood at 21 per cent, up by 300 basis point quarter-on-quarter and 1,170 bps year-on-year. EBITDA margin expansion was led by good...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Why Family Health Insurance Plan needs a Timely Re-Evaluation?

    Why Family Health Insurance Plan needs a Timely Re-Evaluation?

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Health Insurance- The Best Backup Plan in Today

    Health Insurance- The Best Backup Plan in Today's Times

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok